2815361-45-4
Chemical Structure
PDE4-IN-29
- CAS No.: 2815361-45-4
- Formula:C27H34N2O8S
- Molecular Weight:546.63
InChIKey: OBEUFEVNQZUBHP-VQCQRNETSA-N
SMILES: O=C1N([C@@H](C2=CC(OCC)=C(OC)C=C2)CS(C)(=O)=O)C(C3=C(NC(C)=O)C=CC(C(CCCC)O)=C31)=O
Biological Activity: PDE4-IN-29 (Compound 55) is an orally active and selective PDE4 inhibitor (including subtypes such as PDE4A1, PDE4B2, PDE4D3) with IC50s of <5 nM against PDE4D3. PDE4-IN-29 inhibits the degradation of cyclic adenosine monophosphate (cAMP), increases intracellular cAMP levels, suppressing the release of inflammatory factors such as TNF-α. PDE4-IN-29 is promising for research of inflammatory diseases including psoriasis, atopic dermatitis, and chronic obstructive pulmonary disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PDE4-IN-29 | PDE4-IN-29 (Compound 55) is an orally active and selective PDE4 inhibitor (including subtypes such as PDE4A1, PDE4B2, PDE4D3) with IC50s of <5 nM against PDE4D3. PDE4-IN-29 inhibits the degradation of cyclic adenosine monophosphate (cAMP), increases intracellular cAMP levels, suppressing the release of inflammatory factors such as TNF-α. PDE4-IN-29 is promising for research of inflammatory diseases including psoriasis, atopic dermatitis, and chronic obstructive pulmonary disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
